Skip to main content

Psoriatic arthritis

      RT @Janetbirdope: Majority are correct. 1/3 of SAPHO meet PsA criteria esp if no osteitis @RheumNow @eular_org @CRASCRRh
      4 years 6 months ago
      Majority are correct. 1/3 of SAPHO meet PsA criteria esp if no osteitis @RheumNow @eular_org @CRASCRRheum @earlyarthritis #EULAR2020 https://t.co/B9wp8JxWpI
      RT @Janetbirdope: What % of SAPHO pts do you think have PsA? More if synovitis Less if osteitis #EULAR2020 @eular_org @
      4 years 6 months ago
      What % of SAPHO pts do you think have PsA? More if synovitis Less if osteitis #EULAR2020 @eular_org @RheumNow @CRASCRRheum AB0038
      RT @drpnash: #Upadacitinib #psoriaticarthritis Upa works in PsA including imaging and when they show it surprising good
      4 years 6 months ago
      #Upadacitinib #psoriaticarthritis Upa works in PsA including imaging and when they show it surprising good PASI scores as well https://t.co/ZWqj8ythHB
      RT @drpnash: #guselkumab #axialdisease - who would have thunk it - IL23 p19 works in axial involvement PsA with radiolog
      4 years 6 months ago
      #guselkumab #axialdisease - who would have thunk it - IL23 p19 works in axial involvement PsA with radiology! https://t.co/TaSFBJFRnx
      RT @Janetbirdope: Filgo reduces PsA markers OP0224. ? Unique to filgo, a JAK1 effect , class effect or part of any effec
      4 years 6 months ago
      Filgo reduces PsA markers OP0224. ? Unique to filgo, a JAK1 effect , class effect or part of any effective PsA Rx or some of the above? @eular_org @RheumNow @CRASCRRheum @earlyarthritis #EULAR2020 https://t.co/2O5wsLPNl2
      RT @drdavidliew: To truly address adherence, you need to understand what is impairing it, and tailor an approach to over
      4 years 6 months ago
      To truly address adherence, you need to understand what is impairing it, and tailor an approach to overcome those barriers. Great to see this articulated in EULAR recommendations re: non-adherence - a big factor in our therapeutic outcomes! EULAR projects #EULAR2020 @RheumNow https://t.co/0pazcDFTuV
      RT @philipcrobinson: ASAS modification of the Berlin algorithm and the duet algorithm for diagnosing axSpA : results fro
      4 years 6 months ago
      ASAS modification of the Berlin algorithm and the duet algorithm for diagnosing axSpA : results from the screening in axSpA for psoriasis, iritis, and colitis cohort: Abstract FRI0298 #EULAR2020 @RheumNow https://t.co/BkG7c2riRb https://t.co/f63MsxWmd3
      RT @philipcrobinson: Drug retention rates & treatment outcomes in 1,860 axSpA patients Rx with secukinumab in routin
      4 years 6 months ago
      Drug retention rates & treatment outcomes in 1,860 axSpA patients Rx with secukinumab in routine clinical practice in 13 European countries in the EuroSpA research collaboration network -> registry data drug retention rates THU0398 @RheumNow #EULAR2020 https://t.co/x3Y4tMetij https://t.co/DkUyIfyWwS
      RT @philipcrobinson: The Relative Diagnostic Utility of inflamm back pain criteria in inception cohort with PsO, Iritis,
      4 years 6 months ago
      The Relative Diagnostic Utility of inflamm back pain criteria in inception cohort with PsO, Iritis, & Colitis Presenting With Undiagnosed Back Pain: All IBP criteria have poor diagnostic utility for dx of axSpA, esp in PsO Abs SAT0378 #EULAR2020 @RheumNow https://t.co/Y7sbtJtm3U https://t.co/P9q7uJozZ9
      RT @philipcrobinson: Filgotinib was associated with significant reduction in SIJ erosion scores in axSpA: imaging data f
      4 years 6 months ago
      Filgotinib was associated with significant reduction in SIJ erosion scores in axSpA: imaging data from the double-blind, randomized Tortuga trial #EULAR2020 @rheumnow THU0377 https://t.co/1b18Uyvo5j https://t.co/zBXCwGc0Q7
      ×